These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6244978)

  • 1. Fasciola hepatica: effect of 4-amino-6-trichloroethenyl-1,3-benzenedisulfonamide on glycolysis in vitro.
    Schulman MD; Valentino D
    Exp Parasitol; 1980 Apr; 49(2):206-15. PubMed ID: 6244978
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of action of MK-401 against Fasciola hepatica: inhibition of phosphoglycerate kinase.
    Schulman MD; Ostlind DA; Valentino D
    Mol Biochem Parasitol; 1982 Mar; 5(3):133-45. PubMed ID: 7088033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pharmacokinetic basis for the efficacy of 4-amino-6-trichloroethenyl-1,3,-benzenedisulfonamide against Fasciola hepatica in the rat.
    Schulman MD; Valentino D; Cifelli S; Lang R; Ostlind DA
    J Parasitol; 1979 Aug; 65(4):555-61. PubMed ID: 512752
    [No Abstract]   [Full Text] [Related]  

  • 4. 4-amino-6-(trichloroethenyl)-1,3-benzenedisulfonamide, a new, potent fasciolicide.
    Mrozik H; Bochis RJ; Eskola P; Matzuk A; Waksmunski S; Olen LE; Schwartzkopf G; Grodski A; Linn BO; Lusi A; Wu MT; Shunk CH; Peterson LH; Milkowski JD; Hoff DR; Kulsa P; Ostlind DA; Campbell WC; Riek RF; Harmon RE
    J Med Chem; 1977 Sep; 20(9):1225-7. PubMed ID: 926125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a benzenedisulfonamide against experimental Fasciola hepatica infections in calves.
    Wyckoff JH; Bradley RE
    Am J Vet Res; 1983 Nov; 44(11):2203-4. PubMed ID: 6650967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of phosphoglycerate kinase from Fasciola hepatica.
    Schulman MD; Valentino D
    Mol Biochem Parasitol; 1981 Apr; 2(5-6):309-21. PubMed ID: 7242569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasciola hepatica: energy sources and metabolism.
    Coles GC; Simpkin KG; Barrett J
    Exp Parasitol; 1980 Feb; 49(1):122-7. PubMed ID: 7350000
    [No Abstract]   [Full Text] [Related]  

  • 8. The relationship of some intermediary metabolites to the production of volatile fatty acids by adult Fasciola hepatica.
    Lahoud H; Prichard RK; McManus WR; Schofield PJ
    Comp Biochem Physiol B; 1971 Jul; 39(3):435-44. PubMed ID: 5122680
    [No Abstract]   [Full Text] [Related]  

  • 9. Activity of oxyclozanide, nitroxynil, clorsulon and albendazole against adult triclabendazole-resistant Fasciola hepatica.
    Coles GC; Stafford KA
    Vet Rec; 2001 Jun; 148(23):723-4. PubMed ID: 11430684
    [No Abstract]   [Full Text] [Related]  

  • 10. The dissimilation of leucine, isoleucine and valine to volatile fatty acids by adult Fasciola hepatica.
    Lahoud H; Prichard PK; McManus WR; Schofield PJ
    Int J Parasitol; 1971 Dec; 1(3):223-33. PubMed ID: 5156166
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of diamfenetide on metabolic and excretory functions of Fasciola hepatica in vitro.
    Rew RS; Fetterer RH
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1984; 79(2):353-5. PubMed ID: 6151466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics of carbohydrate-fat metabolis in Fasciola and action of specific anthelmintics].
    Senutaĭte IaIu
    Med Parazitol (Mosk); 1971; 40(3):336-41. PubMed ID: 5098438
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of hormones on carbohydrate metabolism of invertebrates.
    Mansour TE
    Fed Proc; 1967; 26(4):1179-85. PubMed ID: 4226286
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative efficacy of clorsulon and albendazole against Fasciola hepatica in cattle.
    Kilgore RL; Williams ML; Benz GW; Gross SJ
    Am J Vet Res; 1985 Jul; 46(7):1553-5. PubMed ID: 4026039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-dependent pharmacokinetics and efficacy of MK-401 against old, and young-mature infections of Fasciola hepatica in the rat.
    Schulman MD; Valentino D; Cifelli S; Ostlind DA
    J Parasitol; 1982 Aug; 68(4):603-8. PubMed ID: 7119988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in energy metabolism due to anthelmintics in Fasciola hepatica maintained in vitro.
    Cornish RA; Bryant C
    Int J Parasitol; 1976 Oct; 6(5):393-8. PubMed ID: 965144
    [No Abstract]   [Full Text] [Related]  

  • 17. The metabolic integrity of Fasciola hepatica during in vitro maintenance.
    Cornish RA; Bryant C
    Int J Parasitol; 1976 Oct; 6(5):387-92. PubMed ID: 965143
    [No Abstract]   [Full Text] [Related]  

  • 18. ATP synthesis in a succinate decarboxylase system from Fasciola hepatica mitochondria.
    Köhler P; Bryant C; Behm CA
    Int J Parasitol; 1978 Oct; 8(5):399-404. PubMed ID: 751992
    [No Abstract]   [Full Text] [Related]  

  • 19. Does insulin affect carbohydrate metabolism in Fasciola hepatica?
    Isseroff H; Read CP
    Comp Biochem Physiol; 1968 Mar; 24(3):1069-72. PubMed ID: 5650482
    [No Abstract]   [Full Text] [Related]  

  • 20. Purification, characterization and inhibition by MK-401 of Fasciola hepatica phosphoglyceromutase.
    Schulman MD; Valentino D
    Mol Biochem Parasitol; 1982 May; 5(5):321-32. PubMed ID: 6285191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.